5-Fluorouracil/leucovorin versus capecitabine in patients with stage III colon cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference15 articles.
1. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue;Miwa;Eur J Cancer,1998
2. Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts;Ishikawa;Biochem Pharmacol,1998
3. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma;Takebayashi;J Natl Cancer Inst,1996
4. Antitumor activities of a novel fluoropyrimidine, N4-pentyloxycarbonyl5′-deoxy-5-fluorocytidine (capecitabine);Ishikawa;Biol Pharm Bull,1998
5. Preferential activation of capecitabine in tumor following oral administration to colorectal patients;Schuller;Cancer Chemother Pharmacol,2000
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Safety of capecitabine: a review;Expert Opinion on Drug Safety;2010-08-19
2. The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer;Cancer Chemotherapy and Pharmacology;2005-08-20
3. The Benefit of Post-Operative Adjuvant Chemotherapy Using Oral Fluoropyrimidines in Rectal Cancer;The Kurume Medical Journal;2005
4. Results of Two Open-Label, Multicenter Phase II Studies of Docetaxel, Platinum Salts, and Trastuzumab in HER2-Positive Advanced Breast Cancer;JNCI Journal of the National Cancer Institute;2004-05-18
5. Cancers of the large bowel and hepatobiliary tract;Cancer Chemotherapy and Biological Response Modifiers Annual;2003
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3